Increase in serum 5 alpha-androstane-3 alpha,17 beta-diol glucuronide as a possible marker of the androgen-mediated immunosuppressive activity exerted by cyclosporin A: preliminary results.
Cutolo
M
M
Sulli
A
A
Giusti
M
M
Barone
A
A
Seriolo
B
B
Accardo
S
S
D000328:Adult; D000728:Androgens / Q000378:metabolism / Q000502:physiology*; D015113:Androstane-3,17-diol / Q000031:analogs & derivatives* / Q000097:blood; D015535:Arthritis, Psoriatic / Q000097:blood / Q000188:drug therapy / Q000378:metabolism; D016572:Cyclosporine / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy; D008297:Male; D008875:Middle Aged; D013739:Testosterone / Q000097:blood
D000728:Androgens; D015113:Androstane-3,17-diol; C028895:androstane-3,17-diol glucuronide; D013739:Testosterone; D016572:Cyclosporine